Search Ontology:
ChEBI
oxolucidine B
- Term ID
- CHEBI:7849
- Synonyms
-
- (1R,2S,5S,9S,11R,13S,17R)-5-{[(4aS,5R,7S,8aR)-1-acetyl-7-methyldecahydroquinolin-5-yl]methyl}-11,14-dimethyl-6,14-diazatetracyclo[7.6.2.0(2,7).0(13,17)]heptadec-6-en-2-ol
- (4aS,5R,7S,8aR)-1-acetyl-5-[[(2S,4aS,5R,6aR,7S,9R,10aS)-3,4,4a,5,6,6a,7,8,9,10,10a,11-dodecahydro-4a-hydroxy-9,12-dimethyl-7,5-(iminomethano)-2H-benzo[5,6]cyclohepta[1,2-b]pyridin-2-yl]methyl]decahydro-7-methylquinoline
- Oxolucidine B
- Serratanine B
- Definition
- An organonitrogen heterocyclic compound that is lucidine B in which the hydrogen at the 4a position of the dodecahydrobenzo[5,6]cyclohepta[1,2-b]pyridinyl moiety is substituted by a hydroxy group.
- References
-
- CAS:71384-25-3
- KEGG:C09891
- KNApSAcK:C00001953
- PMID:10731030
- PMID:15565253
- Reaxys:8600822
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_functional_parent
-
Phenotype
Phenotype resulting from oxolucidine B
Phenotype where environments contain oxolucidine B
Phenotype modified by environments containing oxolucidine B
Human Disease / Model Data